Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003619279 | SCV004471891 | uncertain significance | Succinyl-CoA acetoacetate transferase deficiency | 2023-01-24 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Arg468 amino acid residue in OXCT1. Other variant(s) that disrupt this residue have been observed in individuals with OXCT1-related conditions (PMID: 21296660, 28488182, 33596448), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt OXCT1 protein function. This missense change has been observed in individual(s) with succinyl-CoA:3-oxoacid coenzyme A transferase (SCOT) deficiency (PMID: 33596448; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 468 of the OXCT1 protein (p.Arg468His). |